ZIM LABORATORIES LTD - Press Release For Grant Of Marketing Authorization For Azithromycin For Oral Suspension 200 Mg/5Ml (40 Mg/Ml) In Portugal, Europe

Rediff Moneywiz

Hi Guest
Feedback

Zim Laboratories Ltd - Press Release For Grant Of Marketing Authorization For Azithromycin For Oral Suspension 200 Mg/5Ml (40 Mg/Ml) In Portugal, Europe

Download	< Back
22 Jul 2024
Please find enclosed press release for grant of marketing authorisation for Azithromycin for oral suspension 200 mg / 5 ml (40 mg/ml) in Portugal, Europe to the wholly owned European subsidiary of the Company.
View all announcements for Zim Laboratories Ltd	Source: BSE India

ALL MONEYWIZ PAGES